Lexagene Holdings (Lexagene Holdings) Total Assets : $3.49 Mil (As of Nov. 2022)

View and export this data going back to 2017. Start your Free Trial

What is Lexagene Holdings Total Assets?

Lexagene Holdings's Total Assets for the quarter that ended in Nov. 2022 was $3.49 Mil.

Total Assets is connected with ROA %. Lexagene Holdings's annualized ROA % for the quarter that ended in Nov. 2022 was -174.68%. Total Assets is also linked to Revenue through Asset Turnover. Lexagene Holdings's Asset Turnover for the quarter that ended in Nov. 2022 was 0.01.

Lexagene Holdings Total Assets Historical Data

The historical data trend for Lexagene Holdings's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lexagene Holdings Total Assets Chart

Lexagene Holdings Annual Data

Trend

Mar13

Mar14

Mar15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Total Assets

Get a 7-Day Free Trial

3.72

1.70

5.99

13.20

8.20

Lexagene Holdings Quarterly Data
	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22
Total Assets	Get a 7-Day Free Trial															5.36	8.20	6.13	4.20	3.49

Lexagene Holdings Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Lexagene Holdings's Total Assets for the fiscal year that ended in Feb. 2022 is calculated as

Total Assets	=	Total Equity (A: Feb. 2022 )	+	Total Liabilities (A: Feb. 2022 )
	=	6.38	+	1.819
	=	8.20

Lexagene Holdings's Total Assets for the quarter that ended in Nov. 2022 is calculated as

Total Assets	=	Total Equity (Q: Nov. 2022 )	+	Total Liabilities (Q: Nov. 2022 )
	=	1.273	+	2.217
	=	3.49

Lexagene Holdings (OTCPK:LXXGQ) Total Assets Explanation

Total Assets is connected with ROA %.

Lexagene Holdings's annualized ROA % for the quarter that ended in Nov. 2022 is

ROA %	=	Net Income (Q: Nov. 2022 )	/	( (Total Assets (Q: Aug. 2022 )	+	Total Assets (Q: Nov. 2022 ))	/ count )
	=	-6.712	/	( (4.195	+	3.49)	/ 2 )
	=	-6.712	/	3.8425
	=	-174.68 %

Note: The Net Income data used here is four times the quarterly (Nov. 2022) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Lexagene Holdings's Asset Turnover for the quarter that ended in Nov. 2022 is

	Asset Turnover
=	Revenue (Q: Nov. 2022 )	/	( (Total Assets (Q: Aug. 2022 )	+	Total Assets (Q: Nov. 2022 ))	/ count )
=	0.043	/	( (4.195	+	3.49)	/ 2 )
=	0.043	/	3.8425
=	0.01

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Lexagene Holdings Total Assets Related Terms

Thank you for viewing the detailed overview of Lexagene Holdings's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Lexagene Holdings (Lexagene Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lexagene Holdings Inc (OTCPK:LXXGQ) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

500 Cummings Center, Suite 4550, Beverly, MA, USA, 01915

Website

https://www.lexagene.com

Lexagene Holdings Inc is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The MiQLab system delivers sensitivity, specificity, and breadth of detection and can return results in approximately two hours. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.